What I Took Away From Talking Peptides and Bioregulators With Sarah Morgan

I recently sat down with Sarah Morgan -a nutrition biochemist who started out on the path to becoming a cardiologist before she pivoted into functional health, genetics, and now peptide education — to talk about bioregulators, peptides, and amino acids. There's a lot of noise in this category right now, and a lot of it is either fear-based or hype-based. So I wanted to get past that and just talk plainly about what these molecules actually are and why they matter. A few things from that conversation are worth passing along.

Your body already does this

The first thing worth clearing up is that peptides aren't some foreign technology being introduced into the body. As Sarah put it, our bodies make about 7,000 of them every single day. A peptide is simply a chain of amino acids — think of amino acids as letters that get arranged into words, and those words become messages the body sends from one place to another. A peptide attaches to a receptor on a cell and tells that cell to do something it's already designed to do.

Bioregulators are a smaller, more specific category within that — tiny peptides, usually just two to four amino acids long. Because of their size, they can actually get inside the cell, into the nucleus, and influence gene expression and chromatin. Sarah described it as something like a light switch sitting on top of your biochemistry. That distinction matters, because it reframes the whole conversation. These aren't synthetic add-ons fighting against the body. They're the body's own signaling language, and in a lot of cases we're just supplying more of a message the body would be sending anyway if it weren't so compromised by stress, depleted food, and toxic load.

GLP-1s aren't good or evil — the dose and the intent are what matter

GLP-1 came up early, and for good reason — it's probably the most talked-about (and most polarizing) peptide category right now. Sarah made a point that stuck with me: the body already produces GLP-1 agonists on its own. These were actually discovered by studying gastric bypass patients and asking what the body was releasing from the stomach into the small intestine. The receptors for it show up in the pancreas, the brain, and the immune system, which is why the effects go so far beyond blood sugar.

Where it goes wrong, in Sarah's view, is aggressive overdosing chasing weight loss as the only metric, while ignoring everything else happening in the body. That's compounded by a shame narrative around weight that has nothing to do with physiology and everything to do with culture. I've said for years that I don't love the term "weight loss" — it lumps together losing fat, losing bone density, losing muscle, and losing fluid as if they're the same thing, when they're not even close. A supported body knows what its correct weight is. I've watched my own weight go up seven or eight pounds on a scale with zero change in body size, simply because I'd gone from dehydrated to properly hydrated. The number on the scale isn't the story.

The body doesn't work in silos, even when medicine does

One of the things Sarah is most excited about is what's now showing up in the research on GLP-1 use beyond weight — reduced risk markers for certain cancers, less neuroinflammation, remission in some autoimmune cases. Her point was that conventional medicine tends to split the body into departments — a cardiologist for the heart, another specialist for something else — while peptides force you to look at the body as one connected system, because a single signaling molecule can touch the pancreas, the brain, and the immune system all at once. That's closer to how the body actually behaves. The hip bone actually is connected to the leg bone, connected to the brain, connected to everything else.

That same logic is why I keep coming back to iodine and to feeding the brain properly. If the brain loses clean communication with the rest of the body, everything downstream gets harder — including the very insulin regulation and hunger signaling that GLP-1 is being used to patch. Sarah mentioned protocols where properly fueling the brain has helped people manage type 1 and type 2 diabetes in a matter of months. That's not a cure, and it's not magic — it's the brain regaining communication with an organ it had lost touch with.

Cellular memory is a real thing, and it changes how we should think about "success"

This was probably the most useful new piece of information for me. Sarah explained that when people lose weight on GLP-1s and then go off them, the majority regain a significant portion of it — sometimes all of it, and quickly. The reason isn't a lack of willpower. Recent research shows that fat cells and immune cells retain an epigenetic memory of the prior state. A fat cell that has been fat wants to be fat again, even after weight loss, and immune cells stay primed toward inflammation even once symptoms improve. In mouse models, reprogramming that memory back to a healthy baseline appears to take somewhere in the range of five to ten years.

That reframes the entire weight conversation. Peptides can modulate things on the surface, but epigenetic reprogramming is the deeper work, and it's still early days for how we measure and support that process. It's also why Sarah is so focused on kids' health — a child who gains weight develops more fat cells than an adult does, and that cellular memory gets written early. Prevention isn't just a nice idea there; it's doing a lot of the epigenetic work before it ever has to be undone.

Regulation is the point, not just a category name

Bioregulators, unsurprisingly, are about helping the body regulate itself — nervous system included. Sarah brought up Selank as an example, a peptide that supports GABA signaling and helps someone move out of a chronic fight-or-flight state into something calmer and more focused. That lines up with something I think about a lot: staying level-headed under pressure is a trained skill, not a personality trait. A five-star general doesn't get to have a meltdown; that's simply not available to someone operating at that level of responsibility. The goal with the body is similar — building enough physiological regulation that stress doesn't have to hijack the whole system every time something unexpected happens.

None of it replaces the fundamentals

Sarah was clear that no peptide, bioregulator, or nutrient is a magic bullet on its own. Protein intake, movement, sleep, and micronutrient status all still have to be in place for any of this signaling to do its job well. She also made a point I appreciated about life stage — pushing hard with intense training might build mitochondrial density in your thirties, but the same approach during perimenopause can just tax an already-shifting endocrine system. It's less about finding the one right protocol and more about knowing what your body actually needs right now.

She also talked about rebuilding play back into her own life after burning out as a startup founder — joining an adult soccer team, and finding it did more for her overall regulation than almost anything else she'd tried. It's a good reminder that health isn't only biochemistry. Isolation and over-seriousness take a physiological toll too.

Where this is headed

Sarah is building out peptide education — a course for healthcare professionals already exists, with a consumer-focused version and more content on the way. If you want to go deeper into any of this, she's at sarahmorgan.co and aminoacademy.com.

None of this is a finished picture. The research on epigenetic regulation with bioregulators is still young, personalized measurement tools are still being built, and there's plenty here that neither of us claimed to have fully figured out. That's probably the most honest way to leave it — this is a category worth paying attention to, worth using responsibly, and worth continuing to learn about as the data catches up to the interest.